Company Filing History:
Years Active: 2003
Title: Innovations of Zhengwei Peng in Pharmaceutical Chemistry
Introduction
Zhengwei Peng is a notable inventor based in San Diego, California, recognized for his contributions to pharmaceutical chemistry. He holds two patents that focus on compounds aimed at inhibiting protein kinases, which play a crucial role in various cellular processes.
Latest Patents
His latest patents include "Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use" and "Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use." Additionally, he has developed "Diaminothiazole compounds that modulate and/or inhibit the activity of certain protein kinases." These innovations are designed to mediate tyrosine kinase signal transduction, which can help modulate and inhibit unwanted cell proliferation. The therapeutic applications of these compounds extend to treating cancer and other diseases associated with unwanted angiogenesis and cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis.
Career Highlights
Zhengwei Peng is currently employed at Agouron Pharmaceuticals, Inc., where he continues to advance his research in the field of pharmaceutical compositions. His work is pivotal in developing new treatments that can significantly impact patient care and disease management.
Collaborations
He collaborates with esteemed colleagues, including Steven Lee Bender and Dilip Ramakant Bhumralkar, to further enhance the scope and application of his research.
Conclusion
Zhengwei Peng's innovative work in pharmaceutical chemistry exemplifies the potential of targeted therapies in modern medicine. His patents contribute significantly to the fight against various diseases, showcasing the importance of research and development in improving health outcomes.